Biomedical Systems Announces Vice President, Imaging Services
Biomedical Systems, a global provider of centralized diagnostic testing for the pharmaceutical and medical device industry, recently announced the promotion of Sam Dranoff to Vice Present of Business Development, Imaging Services.
Biomedical Systems Announces Vice President, Imaging Services
August 27, 2008 – St. Louis, MO – Biomedical Systems, a global leader in centralized diagnostic testing for the pharmaceutical and medical device industry, recently announced the promotion of Sam Dranoff to Vice Present of Business Development, Imaging Services. Dranoff will continue with his current responsibilities while growing a team of global business development directors for Biomedical Systems, Imaging Services. The business unit has experienced significant growth since Dranoff joined the division in 2005, and most recently served as Managing Director, Commercial Operations.
"We have grown the imaging business to a point where we see a need for expanding the Business Development team. Sam has the proven experience and talent to grow and manage this team as well as the vision to see it succeed. That is why I'm so excited that he has accepted this new position and I'm confident that he will add great value in his new role." said Jesse Bowden, President of Imaging Services, Biomedical Systems.
Biomedical Systems is a fully digital imaging core lab that supports clinical trials in dozens of therapeutic categories. Leveraging combined corporate resources that includes ECG core lab and respiratory core lab, Biomedical Imaging Services provides sponsors unmatched diagnostic service offerings on a global basis.
Biomedical Systems is a global provider of centralized diagnostic services for the pharmaceutical and medical device industries. With offices in North America, Europe and Asia, Biomedical Systems has worked with over 11,000 investigative sites in 75 countries around the world for Phase I - IV clinical trials. Biomedical Systems centralized services include the acquisition, analysis and management of data for Cardiac, Imaging and Respiratory modalities used to determine safety and efficacy for drugs and devices in clinical trials. For more information about Biomedical Systems, please contact Traci Cardenas, Marketing Manager at 1-800-877-6334 (3338) or via email, tcardenas@biomedsys.com. Additional information can be found on the company website at www.biomedsys.com.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
